DSIJ Mindshare

Looking at the full year numbers, we see that the revenue jumped by one per cent to reach Rs.7318.63 crore, while its EBITDA fell by 36 per cent to Rs 266.73 crore.

Subros reported strong quarter for Q4FY18 with operational profit and net profit recording strong growth compared to previous year.

The research houses upgraded Sun Pharma’s rating after its Q4FY18 results. It urged more than 7 per cent in Monday’s trade, uplifting the Nifty Pharma Index by 2.4 per cent. The stock bounced back from 435 level up to 61.8 per cent retracement of the downward rally from 539 levels.

Caplin Point Laboratories reported mixed results across the board. The revenue and operating profit grew strongly, while bottom-line increased minimally.